BBA
BLB&B Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-18,996
| Closed | -$334K | – | 315 |
|
|
2017
Q3 | $334K | Sell |
18,996
-8,910
| -32% | -$157K | 0.05% | 215 |
|
|
2017
Q2 | $927K | Buy |
27,906
+674
| +2% | +$22.4K | 0.15% | 130 |
|
|
2017
Q1 | $874K | Buy |
27,232
+650
| +2% | +$20.9K | 0.15% | 132 |
|
|
2016
Q4 | $964K | Sell |
26,582
-521
| -2% | -$18.9K | 0.17% | 127 |
|
|
2016
Q3 | $1.25M | Buy |
27,103
+1,128
| +4% | +$51.9K | 0.23% | 106 |
|
|
2016
Q2 | $1.31M | Sell |
25,975
-3
| -0% | -$151 | 0.25% | 101 |
|
|
2016
Q1 | $1.39M | Buy |
25,978
+302
| +1% | +$16.2K | 0.28% | 96 |
|
|
2015
Q4 | $1.69M | Sell |
25,676
-898
| -3% | -$58.9K | 0.36% | 83 |
|
|
2015
Q3 | $1.5M | Sell |
26,574
-4,281
| -14% | -$242K | 0.33% | 88 |
|
|
2015
Q2 | $1.82M | Sell |
30,855
-1,220
| -4% | -$72.1K | 0.38% | 80 |
|
|
2015
Q1 | $2M | Buy |
32,075
+1,203
| +4% | +$74.9K | 0.42% | 72 |
|
|
2014
Q4 | $1.78M | Buy |
30,872
+202
| +0.7% | +$11.6K | 0.38% | 72 |
|
|
2014
Q3 | $1.65M | Sell |
30,670
-67
| -0.2% | -$3.6K | 0.36% | 75 |
|
|
2014
Q2 | $1.61M | Sell |
30,737
-100
| -0.3% | -$5.24K | 0.34% | 75 |
|
|
2014
Q1 | $1.63M | Sell |
30,837
-100
| -0.3% | -$5.28K | 0.36% | 72 |
|
|
2013
Q4 | $1.24M | Sell |
30,937
-254
| -0.8% | -$10.2K | 0.3% | 85 |
|
|
2013
Q3 | $1.18M | Buy |
31,191
+497
| +2% | +$18.8K | 0.31% | 81 |
|
|
2013
Q2 | $1.2M | Buy |
+30,694
| New | +$1.2M | 0.33% | 80 |
|